信達生物(01801.HK)與禮來(LLY.US)宣布，就禮來非共價(可逆)BTK抑制劑「捷帕力」(匹妥布替尼100毫克和50毫克片劑)在中國大陸的權益達成合作協議，將由信達生物負責捷帕力的進口、銷售... 信達生物(01801.HK) -0.950 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback